Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

712
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
712
Crossover Experiments01:16

Crossover Experiments

3.4K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
3.4K
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

1.6K
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
1.6K
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

419
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
419
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

596
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
596
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

492
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
492

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Covariate Adjustment for Wilcoxon Two Sample Statistic and Test.

Statistics in medicine·2026
Same author

Practical considerations when using the covariate-adjusted log-rank test for the analysis of time-to-event endpoints in oncology trials.

Biometrics·2026
Same author

Covariate adjustment in randomized clinical trials: From general theory to practical insights.

Clinical trials (London, England)·2026
Same author

Right and Left Atrial Dysfunction as Independent Cardiovascular Risk Factors: A UK Biobank Study.

Circulation. Arrhythmia and electrophysiology·2026
Same author

Plasma proteomics and incident coronary heart disease.

Communications medicine·2026
Same author

All Lines Is the Right Approach: Selecting Patient Lines of Therapy for an External Comparator Arm.

Pharmacoepidemiology and drug safety·2025

Related Experiment Video

Updated: May 1, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.3K

Adaptive Designs in Trials With Time-to-Event Endpoints and Covariate Adjustment.

Daniel Backenroth1, Ting Ye2

  • 1Johnson & Johnson, Raritan, New Jersey, USA.

Statistics in Medicine
|April 30, 2026
PubMed
Summary
This summary is machine-generated.

Adaptive designs enhance clinical trial efficiency using covariate-adjusted log-rank tests. However, actual efficiency gains may differ from estimates, posing risks for sample size reduction.

Keywords:
adaptive designscovariate adjustmentinformation monitoringtime‐to‐event data

More Related Videos

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.4K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

9.9K

Related Experiment Videos

Last Updated: May 1, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.3K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.4K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

9.9K

Area of Science:

  • Clinical Trials
  • Biostatistics
  • Statistical Methods

Background:

  • Adaptive designs can improve clinical trial efficiency by leveraging covariate-adjusted log-rank tests for time-to-event endpoints.
  • A key challenge is the discrepancy between estimated and actual efficiency gains from covariate adjustment during trial design.

Purpose of the Study:

  • To investigate adaptive designs that capitalize on efficiency gains from the covariate-adjusted log-rank test.
  • To evaluate information-based interim monitoring and blinded event target adjustment (BETA) for improving efficiency.
  • To analyze the statistical and operational trade-offs between these adaptive approaches.

Main Methods:

  • Utilized two data-generating processes to simulate trial scenarios.
  • Incorporated simulations with repeated testing to compare adaptive designs.
  • Evaluated designs based on statistical power, trial duration, and sample size reduction.

Main Results:

  • Regression coefficients in covariate-adjusted log-rank tests can increase over time, leading to greater variance reductions with extended follow-up.
  • Blinded Event Target Adjustment (BETA) may not fully capture these increasing efficiency gains.
  • Information-based monitoring allows faster analyses with prognostic covariates but can be operationally complex.

Conclusions:

  • Information-based monitoring offers speed but operational burdens; BETA provides simplicity but may underutilize covariate adjustment efficiency.
  • Reducing sample size with adaptive designs carries risks, potentially leading to longer trial durations if initial efficiency estimates are overly optimistic.